Prelude Therapeutics (PRLD)'s 30-day implied volatility (IV30) was 106.8% at the close on November 5, 2026, up from 98.9% the day before, against a 52-week range of 81.5% to 248.9%. Its 20-day historical volatility was 82.0%.
Data as of November 5, 2026.